AndrewJohnsrudMD

PubMed

• 1 citations
  Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance.
  Sheren Younes, Shuchun Zhao, Sushma Bharadwaj, Alicia Palomino Mosquera, Diane Libert, Andrew Johnsrud, Robbie G Majzner, David B Miklos, Matthew J Frank, Yasodha Natk...> ;Modern Pathology. 2023 Oct 1
• 27 citations
  Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy
  Andrew Johnsrud, Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly, James L. Zehnder, John S. Tamaresis, Robert S. Negrin, Laura Johnston, Sally Arai, Judith A...> ;Blood Advances. 2021 Nov 9
• 6 citations
  Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafo...
  Andrew Johnsrud, Abdullah Ladha, Lori Muffly, Parveen Shiraz, Gary Goldstein, Victoria Osgood, Judith A. Shizuru, Laura Johnston, Sally Arai, Wen-Kai Weng, Robert Lows...> ;Transplantation and Cellular Therapy. 2021 Jul 1
• 19 citations
  Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations.
  Andrew J Johnsrud, Samir V. Jenkins, A Jamshidi-Parsian, Charles M. Quick, Edvaldo Galhardo, Ruud P.M. Dings, Kieng B. Vang, Ganesh Narayanasamy, Issam Makhoul, Robert...> ;Radiation Research. 2020 Dec 1
• 33 citations
  Infectious and immunological sequelae of daratumumab in multiple myeloma
  Andrew J Johnsrud, Joyce Johnsrud, Sandra Susanibar, Jorge Jo Kamimoto, Atul Kothari, Mary J. Burgess, Frits van Rhee, Juan Carlos Rico> ;British Journal of Haematology. 2019 Apr 1
• 5 citations
  Carcinocythemia (carcinoma cell leukemia)
  Andrew J Johnsrud, Sergio Pina-Oviedo> ;Blood. 2017 Nov 23
• Join now to see all